Suppr超能文献

环状 RNA MTO1/miR-17/QKI-5 调控环路抑制肺腺癌增殖。

A regulatory circuit of circ-MTO1/miR-17/QKI-5 inhibits the proliferation of lung adenocarcinoma.

机构信息

a Thoracic surgery ward one , HeNan Provincial Chest Hospital , Zhengzhou , P.R. China.

出版信息

Cancer Biol Ther. 2019;20(8):1127-1135. doi: 10.1080/15384047.2019.1598762. Epub 2019 Apr 12.

Abstract

Circular RNA (circRNA) is a new class of non-coding RNA that plays a pivotal role in carcinogenesis. Recently, circ-MTO1 (hsa_circ_0007874) was shown to be a cancer-related circRNA. However, its role in lung adenocarcinoma (LUAD) has not been reported. Here, we found that circ-MTO1 was significantly down-regulated in LUAD, which was closely associated with malignant features and dismal prognosis. Enforced expression of circ-MTO1 suppressed the growth of LUAD cells both and . Subsequent mechanism experiments showed that circ-MTO1 served as a sponge of oncogenic miR-17 to increase the expression of RNA-binding protein QKI-5, leading to the inactivation of Notch signaling pathway, thereby restraining the growth of LUAD. Importantly, increased QKI-5 expression caused by circ-MTO1 overexpression in turn promoted circ-MTO1 expression. Clinically, circ-MTO1 expression was strongly positively correlated with QKI-5 expression, but negatively correlated with miR-17 expression. Taken together, our data suggest that circ-MTO1 is a critical negative regulator of LUAD and elucidate the potential molecular mechanism of a novel circ-MTO1/miR-17/QKI-5 feedback loop in inhibiting LUAD progression.

摘要

环状 RNA(circRNA)是一类新的非编码 RNA,在致癌作用中发挥关键作用。最近,circ-MTO1(hsa_circ_0007874)被证明是一种与癌症相关的 circRNA。然而,其在肺腺癌(LUAD)中的作用尚未报道。在这里,我们发现 circ-MTO1 在 LUAD 中显著下调,与恶性特征和预后不良密切相关。circ-MTO1 的过表达抑制了 LUAD 细胞的生长,无论是在体外还是体内。后续的机制实验表明,circ-MTO1 作为致癌 miR-17 的海绵,增加 RNA 结合蛋白 QKI-5 的表达,导致 Notch 信号通路失活,从而抑制 LUAD 的生长。重要的是,circ-MTO1 过表达引起的 QKI-5 表达增加反过来又促进了 circ-MTO1 的表达。临床上,circ-MTO1 的表达与 QKI-5 的表达呈强烈正相关,而与 miR-17 的表达呈负相关。总之,我们的数据表明 circ-MTO1 是 LUAD 的关键负调控因子,并阐明了 circ-MTO1/miR-17/QKI-5 反馈环在抑制 LUAD 进展中的潜在分子机制。

相似文献

引用本文的文献

7
Circular RNAs as biomarkers for lung cancer.环状RNA作为肺癌的生物标志物
Noncoding RNA Res. 2022 Nov 7;8(1):83-88. doi: 10.1016/j.ncrna.2022.11.002. eCollection 2023 Mar.
8
Hotspots and development frontiers of circRNA based on bibliometric analysis.基于文献计量分析的环状RNA研究热点与发展前沿
Noncoding RNA Res. 2022 Mar 21;7(2):77-88. doi: 10.1016/j.ncrna.2022.03.001. eCollection 2022 Jun.

本文引用的文献

1
The novel roles of circRNAs in human cancer.环状 RNA 在人类癌症中的新作用。
Mol Cancer. 2019 Jan 9;18(1):6. doi: 10.1186/s12943-018-0934-6.
4
CircRNAs and cancer: Biomarkers and master regulators.环状 RNA 与癌症:生物标志物和主控调节因子。
Semin Cancer Biol. 2019 Oct;58:90-99. doi: 10.1016/j.semcancer.2018.12.002. Epub 2018 Dec 11.
7
High glucose-induced circHIPK3 downregulation mediates endothelial cell injury.高糖诱导的 circHIPK3 下调介导内皮细胞损伤。
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):362-368. doi: 10.1016/j.bbrc.2018.11.041. Epub 2018 Nov 16.
9
Research progress of circular RNAs in lung cancer.环状 RNA 在肺癌中的研究进展。
Cancer Biol Ther. 2019;20(2):123-129. doi: 10.1080/15384047.2018.1523848. Epub 2018 Nov 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验